These findings collectively suggest that the upregulation of LIN28 into NKG2D-CAR T cells might compromise their cytotoxic potential both in vitro and in vivo, highlighting the critical role of LIN28 in modulating CAR T cell function and anti-tumor responses. The gene discussed is LIN28A; the disease is neoplasm.